Yüklüyor......
Rivastigmine From Capsules to Patch: Therapeutic Advances in the Management of Alzheimer’s Disease and Parkinson’s Disease Dementia
Objective: To discuss the pharmacology, mechanism of action, and chemical properties of the cholinesterase inhibitor (ChEI) rivastigmine; to provide a rationale for transdermal delivery and supportive clinical data, along with practical guidance on rivastigmine patch use in Alzheimer’s disease and P...
Kaydedildi:
| Yayımlandı: | Prim Care Companion CNS Disord |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Physicians Postgraduate Press, Inc.
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4321018/ https://ncbi.nlm.nih.gov/pubmed/25667813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/PCC.14r01654 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|